RECRO PHARMA INC (REPH)

Common Stock

2.09  -0.01 (-0.48%)

After market: 2.09 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
75.36M66.50M99.22M77.35M71.83M
Cost Of Goods
55.54M54.13M50.98M43.16M38.19M
Gross Profit
19.82M12.37M48.24M34.19M33.64M
Operating Expenses
19.41M20.71M24.61M88.23M73.96M
Research and Development
N/A0.000.0039.99M33.10M
Selling, General, and Administrative Expenses
18.37M18.12M19.91M36.88M25.43M
Operating Income
412.00K-8.34M23.63M-54.04M-40.31M
Interest Income/Expense
-15.13M-19.16M-19.01M-8.24M-11.65M
Non Recurring Items
3.35MN/AN/AN/AN/A
Income Before Taxes
-11.37M-27.50M4.63M-62.29M-51.96M
Income Tax
0.000.000.0017.44M-9.78M
Net Income
-11.37M-27.50M-18.63M-79.72M-50.08M
EBITDA
7.98M200.00K32.03M-46.19M-32.87M
 
Per Share Data
EPS Diluted Total Ops
-0.26-1.16-0.83-3.89-2.63
Non GAAP EPS
-0.31-1.150.20-2.49-1.99
 
Statistics
Gross Profit Margin
26.30%18.60%48.62%44.20%46.83%
Profit Margin
-15.09%-41.35%-18.78%-103.06%-69.72%
Operating Profit Margin
0.55%-12.54%23.82%-69.86%-56.12%

All data in USD

Charts